EU to discuss US vaccine patent plan at Friday summit
BRUSSELS (AP) — European Union leaders say that in the wake of the U.S. backing patent waivers for COVID-19 vaccine technology, the 27-nation bloc immediately will start discussing whether they should join such a move. The leaders’ first opportunity to mold a common view will come as soon as a two-day summit in Porto, Portugal, that starts Friday. EU member nations have long insisted they were in the vanguard of helping the rest of the world obtain vaccines, and have looked with a weary eye at how the United States effectively banned such exports itself. The EU on Thursday generally welcomed President Joe Biden’s position, but it didn’t immediately echo it.